Mirabegron

Product NDC
70710-1160
11-digit product format
707101160
Labeler code
70710
Product ID
70710-1160_df34c0c9-8528-4fd6-a408-e1d44da0f156
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Mirabegron
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
Zydus Pharmaceuticals (USA) Inc.
Application
ANDA209488
Marketing category
ANDA
Marketing start
2024-01-23
Substance
MIRABEGRON
Active strength
50 mg/1
Pharmacologic classes
Adrenergic beta3-Agonists [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], beta3-Adrenergic Agonist [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Mirabegron
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
MIRABEGRON50 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiMVR3JL3B2V
Rxcui1300791, 1300801

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c73f394f-7cf1-bcd8-df99-a95ef4373ff6Product name420250116

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70710-1160-12024-03-04C16284748780-11030e365-57fa-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012
70710-1160-32024-03-04C16284748780-11030e365-57fa-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012
70710-1160-92024-03-04C16284748780-11030e365-57fa-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012
70710-1160-12024-01-30C16284748780-11030e365-57fa-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012
70710-1160-32024-01-30C16284748780-11030e365-57fa-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012
70710-1160-92024-01-30C16284748780-11030e365-57fa-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70710-1160-1Mirabegron100 in 1 BOTTLETABLET, EXTENDED RELEASE1003
70710-1160-3Mirabegron30 in 1 BOTTLETABLET, EXTENDED RELEASE303
70710-1160-9Mirabegron90 in 1 BOTTLETABLET, EXTENDED RELEASE903

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70710-1160-3EA - Each70710-116067a31330-7ccc-41da-930b-5b3c67b0a9e812024-05-16
70710-1160-9EA - Each70710-11600d5e02dd-cd41-4db4-b847-f2eed66a972f12024-05-16

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70710-1160MIRABEGRON TABLET, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.]3Current NDC, 3 package rows20241013_2e40eb74-3b2a-47f7-bf31-fe27484f9bd2.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1300791mirabegron 25 MG 24HR Extended Release Oral TabletPSN2e40eb74-3b2a-47f7-bf31-fe27484f9bd23
1300801mirabegron 50 MG 24HR Extended Release Oral TabletPSN2e40eb74-3b2a-47f7-bf31-fe27484f9bd23
1300801mirabegron 50 MG 24HR Extended Release Oral TabletPSN5f7a1758-8691-4e53-96d6-a01626ee81403
130079124 HR mirabegron 25 MG Extended Release Oral TabletSCD2e40eb74-3b2a-47f7-bf31-fe27484f9bd23
130080124 HR mirabegron 50 MG Extended Release Oral TabletSCD2e40eb74-3b2a-47f7-bf31-fe27484f9bd23
130080124 HR mirabegron 50 MG Extended Release Oral TabletSCD5f7a1758-8691-4e53-96d6-a01626ee81403
1300791mirabegron 25 MG 24 HR Release TabletSY2e40eb74-3b2a-47f7-bf31-fe27484f9bd23
1300801mirabegron 50 MG 24 HR Extended Release Oral TabletSY2e40eb74-3b2a-47f7-bf31-fe27484f9bd23
1300801mirabegron 50 MG 24 HR Extended Release Oral TabletSY5f7a1758-8691-4e53-96d6-a01626ee81403

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
70710-1160-170710116001100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1160-1) 2024-01-23NoNoCurrent
70710-1160-37071011600330 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1160-3) 2024-01-23NoNoCurrent
70710-1160-97071011600990 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1160-9) 2024-01-23NoNoCurrent